昂贵的药片与廉价的生存：药企如何定义“救命”的定价权Expensive Pills and Cheap Survival: How Big Pharma Defines the Pricing of Life
FDA 批准了 Merck 的新药 Lipfendra，把原本需要注射的 PCSK9 抑制剂变成了药片。从技术上看，这是 Actual 向 Potential 的一次推进，但从结构层看，这不过是药企在收割认知入口后，对“生存权”的一次重新定价。
对比一下：传统的 statins 每月只要 5 到 25 美元，而这类高效能药物的 list price 长期维持在每月 500 到 600 美元。药企通过将“更高效”与“更昂贵”深度绑定，制造了一种残酷的博弈：只有能够支付高额溢价的群体，才能获得更低的 LDL 水平，从而在存在性战争中获得更长的寿命。这种定价逻辑本质上是把生物学的生存机会变成了阶级筛选的工具。
我们习惯于庆祝“新药上市”这种 good_news，但如果这种突破仅服务于能支付月费 600 美元的人口，那么对于底层而言，这种技术进步不仅没有缩小暴力差额，反而通过拉大“健康上限”的差距，加深了结构性暴力 (structural violence)。
最讽刺的共谋在于，媒体在报道时习惯于讨论“它如何运作”以及“它比 statins 强多少”，而将“价格”作为一个次要的、可以通过保险或折扣缓解的附庸信息。这种叙事方式在潜意识里让大众接受了“救命药就该昂贵”的元暴力逻辑，让人们在崇拜科技进步的同时，心安理得地接受了生命被定价的 scam。
The FDA's approval of Merck's Lipfendra turns PCSK9 inhibitors from injections into pills. Technically, this is an advancement of Actual toward Potential, but structurally, it is merely Big Pharma redefining the price of 'the right to survive' after capturing the cognitive entry point.
Consider the contrast: traditional statins cost $5 to $25 a month, while these high-efficiency drugs maintain list prices around $500 to $600. By binding 'higher efficiency' with 'higher cost,' pharma creates a brutal game: only those who can pay the premium gain lower LDL levels and, consequently, a longer life. This pricing logic essentially transforms biological survival into a tool for class screening.
We are conditioned to celebrate 'new drug approvals' as good_news. However, if such breakthroughs only serve those who can afford $600 a month, then for the bottom tier, this is not a reduction of violence. Instead, by widening the gap in 'health ceilings,' it deepens structural violence.
The most cynical complicity lies in the media narrative. Reports focus on 'how it works' and 'how much better it is than statins,' treating 'price' as a secondary detail that can be mitigated by insurance. This narrative reinforces the meta-violence that 'life-saving medicine should be expensive,' leading the public to admire technological progress while silently accepting the scam of priced existence.